Related articles

• Business

  Richter, Allergan announce positive results for cariprazine

  

  Hungarian drugmaker Gedeon Richter and its Irish peer Allergan on Tuesday announced positive topline results in a Phase III clinical trial of cariprazine for treatment of bipolar I depression, according to a press release sent to the Budapest Business Journal.

   Tue, Apr. 3, 2018, 16:57

  • richter
  • clinical
  • drug
  • cariprazine
  • trial
  • bipolar
• News

  Richter drug wins Innovation Grand Prize

  

  The Hungarian Innovation Foundation has awarded Hungarian drugmaker Gedeon Richter the Innovation Grand Prize for its atypical antipsychotic cariprazine (marketed as Vraylar in the U.S., Reagila in Europe),  a new original Hungarian drug on the global market.

   Thu, Mar. 29, 2018, 09:57

  • gedeon richter
  • innovation
  • prize
  • bogsch
  • cariprazine
• Business

  Richter board proposes HUF 68 per-share dividend

  

  The board of drugmaker Gedeon Richter will propose to shareholders payment of a HUF 68 per-share dividend on last yearʼs earnings at an annual general meeting on April 25, the AGM agenda shows, as reported by national news agency MTI.  

   Fri, Mar. 23, 2018, 10:59

  • richter
  • dividend
  • board
  • agm
• Business

  BUX hit by Richter profit warning over Esmya

  

  Hungarian drugmaker Gedeon Richter said late on Monday it would book a HUF 42 billion impairment loss related to its uterine fibroid drug Esmya, which has come under scrutiny by the European Medicines Agency (EMA) for potentially related liver damage. The Richter share price dropped on Tuesday on the news.

   Tue, Feb. 27, 2018, 13:03

  • richter
  • esmya
  • profit
  • warning
  • bux
  • index
• Finance

  Richter profit plummets on financial loss, taxes

  

  Hungarian drugmaker Gedeon Richterʼs fourth-quarter net income fell 70% year-on-year to HUF 6.6 billion, dragged lower by a financial loss and tax payments, an earnings report published early Monday shows, exceeding the most pessimistic of forecasts of analysts last week. Richterʼs net income for the full year was down 23% at HUF 51.2 bln.

   Mon, Feb. 12, 2018, 08:05

  • richter
  • revenue
  • profit
  • earnings
  • financial loss
  • tax. esmya
• Business

  Richter share price drops as EMA issues Esmya caution

  

  Hungarian pharmaceutical company Gedeon Richter said on Friday that the European Medicines Agency (EMA) has recommended temporarily restricting prescriptions of its uterine fibroid drug Esmya until a review of potentially related liver damage, launched in December, has been completed.  

   Fri, Feb. 9, 2018, 14:43

  • gedeon richter
  • pharmaceutical
  • esmya
  • ema
  • review
• Business

  Richter may postpone guidance pending Esmya review

  

  Hungarian drugmaker Gedeon Richter may hold off on guidance when it publishes fourth-quarter earnings in February if uncertainty continues surrounding Esmya, its drug for the treatment of uterine cysts, CEO Gábor Orbán told news wire Reuters late Friday. 

   Mon, Jan. 8, 2018, 12:19

  • richter
  • esmya
  • guidance
  • review
  • ema
• Business

  BlackRock stake in Richter up over 5% threshold

  

  U.S.-based BlackRockʼs holding in Hungarian drugmaker Gedeon Richter has risen to 5.16%, Richter said yesterday. Richter was informed by BlackRock that its stake had exceeded the 5% disclosure threshold on December 14.   

   Wed, Dec. 20, 2017, 14:02

  • blackrock
  • gedeon richter
  • share
  • threshold
• Whosnews

  Richter chairman gets state award

  

  President of the Republic János Áder on Wednesday decorated Erik Bogsch, the chairman of drugmaker Gedeon Richter, with the Order of Merit of Hungary, Grand Cross, at a ceremony attended by Prime Minister Viktor Orbán and House Speaker László Kövér.   

   Fri, Dec. 1, 2017, 09:00

  • richter
  • bogsch
  • award
  • state
  • orban
  • ader
• Business

  Richter profit climbs 14% in Q3

  

  Hungarian drugmaker Gedeon Richterʼs third-quarter net income rose 14% to HUF 16.4 billion as revenues climbed, an earnings report released early today shows, cited by state news wire MTI.

   Thu, Nov. 9, 2017, 07:39

  • richter
  • earnings
  • profit
  • revenues
  • pharmaceutical